Full-Time

Medical Science Liaison

Mid Atlantic

Posted on 7/5/2025

Amplity

Amplity

1-10 employees

Global contract services for drug lifecycle

Compensation Overview

$150k - $180k/yr

Washington, DC, USA + 2 more

More locations: Fredericksburg, VA, USA | Baltimore, MD, USA

In Person

Candidates must be based in the Mid Atlantic region.

Category
Medical, Clinical & Veterinary (1)
Requirements
  • Advanced clinical/science degree: MD, PA, NP, PharmD, PhD, RN or NMT preferred
  • 1-2+ years of industry MSL experience is required
  • Knowledge of FDA requirements and PhRMA Code
  • Ability to integrate and work in cross functional network
  • Demonstrated project management ability
  • Excellent oral and written communication skills and interpersonal skills
  • Ability to travel up to 70% (approx.10-12 overnights per month)
  • Valid driver’s license
  • Excellent oral & written communication skills.
  • Ability to influence and build relationships/earn credibility quickly across broad global constituencies with competing priorities.
  • Strong coaching, facilitation, and organizational skills; team player.
  • Experience and skills with cross-functional and highly matrixed organizations.
Responsibilities
  • Maintains a Territory Strategy plan and develops KOL engagement
  • Be knowledgeable in Brand and USMA annual plan
  • Establish a quarterly BED USMA regional scientific network plan for tactical contribution to the Brand and USMA plans.
  • Build and strengthen professional relationships with local/regional/national Urology, Oncology, Nuclear Medicine KOLs, and cancer centers of excellence.
  • Identify and develop advisors, speakers and disease state experts
  • Serve as a key clinical/scientific resource to these specialists/KOLs/cancer centers within assigned geography.
  • Maintain thorough knowledge of disease state, clinical information, and product data within the therapeutic area.
  • Attend national congresses and meetings and, as requested, provide medical and scientific booth support.
  • Professionally represent the company at trade show and conferences, in compliance with industry regulations.
  • Maintain thorough and up-to-date knowledge of imaging techniques, clinical information, and product data within the diagnostic and radiopharmaceutical arena.
  • Maintain current clinical and professional certifications.
  • Develop strategies and tactics to effectively communicate complex scientific information.
  • Ascertain critical competitive intelligence through one-on-ones, group presentations and attendance at medical meetings and appropriately communicate information back to BED’s senior management.
  • Support Clinical/R&D in the facilitation of Investigator Initiated Studies (IISs) and other research initiatives.
  • Identify opportunities to partner with KOLs and principal investigators on disease state education/publication and specific clinical trial initiatives.
  • Support medical education initiatives such as speaker development, advisory board support and serve as a resource to review materials for medical accuracy.
  • Provide technical support and training to field commercial and account teams.
  • To maintain working knowledge of the company’s products, providing guidance and information on products and their use.
  • Appropriately Work with cross-functional teams as agreed upon with your manager to support brand objectives.
  • Adhere to and manage travel and local expenses to meet BED policy while being compliant with all company policy.
  • Other duties as determined by business needs.
Desired Qualifications
  • 2+ years clinical experience within Oncology/Urology/Nuclear Medicine/Imaging preferred

Amplity Health provides medical and commercial outsourcing services to pharmaceutical and healthcare companies across the full drug lifecycle. It uses an AI-driven platform and a HIPAA-compliant database to turn data into insights, while offering contract Medical Science Liaisons and patient support teams to engage with healthcare providers. The company combines data analytics, hands-on medical affairs execution, and a flexible, contract-based workforce to help clients scale as needed. Its goal is to speed up drug development, approvals, and market access while ensuring compliant data handling and efficient resource use.

Company Size

1-10

Company Stage

Debt Financing

Total Funding

$102.5M

Headquarters

Santa Cruz, California

Founded

2010

Simplify Jobs

Simplify's Take

What believers are saying

  • Christina DiBiase's April 2026 CEO appointment drives growth with 17 years experience.
  • Lynx Group 2022 acquisition expands medical communications and omnichannel marketing.
  • 40-year legacy specializes in oncology, rare diseases across 60 countries.

What critics are saying

  • IQVIA's 2025 IPM.ai acquisition erodes Amplity's oncology insights dominance.
  • FDA April 2026 AI guidance halts Ava and AskX deployments by 2027.
  • Ashfield poaches 15% of Amplity's oncology MSLs since January 2026.

What makes Amplity unique

  • Amplity Insights™ analyzes 70 million doctor-patient records to reveal treatment decision 'whys'.
  • In Practice platform delivers oncology intelligence for community oncologists since 2026.
  • Ava AI chatbot enhances personalized digital experiences on Amplity.com.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Unlimited Paid Time Off

Company News

The News Courier
Mar 26th, 2026
Peritia appoints Michael A. Griffith as Chief Executive Officer.

Peritia appoints Michael A. Griffith as Chief Executive Officer. PR Newswire Today at 4:00am PDT Veteran life sciences executive and platform builder brings decades of biopharma leadership to accelerate growth. MORRISVILLE, N.C. and NEW YORK, March 26, 2026 /PRNewswire/ - Peritia, a global biopharmaceutical and medtech consulting company with deep expertise in clinical development and value and evidence generation, today announced the appointment of Michael Griffith as Chief Executive Officer. Mr. Griffith brings more than 25 years of executive leadership experience to build and scale global pharmaceutical services businesses, and his appointment marks a significant milestone in Peritia's evolution. A Platform Builder with Proven Impact Most recently, Mike served as founder and CEO of Amplity Health, a global contract medical and commercial organization operating across 40 countries with more than 1,000 colleagues. Prior to Amplity, he served as Operating Partner at Altamont Capital Partners, where he led investments in biopharmaceutical outsourcing businesses, and as President of the Commercial Division of inVentiv Health, a leading global provider of biopharmaceutical outsourcing services across the research and commercialization continuum. His career also includes CEO stints at ChiRex, Aptuit, and Laureate Biopharma - each a recognized leader in contract drug development and manufacturing - as well as board service at Repligen Corporation and other public life sciences companies. He holds a Master of Management degree from Northwestern University's Kellogg School of Management. "As biopharma and medtech innovator funding continues to build, Peritia is exactly the kind of platform the industry needs right now - one that combines scientific depth, strategic advisory, and operational capability to our client engagements," said Mike Griffith. Peritia has successfully completed more than 1,100 engagements in 20 countries for 355 clients in the past five years. "Now we have the opportunity to scale the enterprise with purpose by building on the strong foundation that's already been established. Our goal is to be a trusted partner for biotech, pharma, and medtech innovators who require additional power to navigate clinical development and health economics." Griffith's appointment comes on the heels of Peritia's formal rebranding and consolidation of BioBridges, CHEORS, and Monitorforhire into a unified platform spanning corporate and product strategy, operational execution, and value, evidence, and access. His track record of building high-performance cultures and scaling life sciences service organizations positions him to accelerate Peritia's mission of guiding life sciences organizations from concept to commercialization. For media inquiries or to learn more about how Peritia can support your programs, please contact us at us at [email protected] or visit www.peritia.com, or visit our LinkedIn page at https://www.linkedin.com/company/peritiaholdings/ About Peritia Peritia is a global biopharmaceutical and medtech consulting company specializing in clinical development and value and evidence generation. We connect industry-leading talent with organizations across the life sciences ecosystem to help bring innovations to patients efficiently and effectively. In the last five years, Peritia has completed more than 1,100 engagements for 335 clients worldwide. Peritia \puh-rish-uh\ noun: the state or quality of being experienced. SOURCE Peritia This is a paid placement. For further inquiries, please contact PR Newswire directly.

Amplity
Jul 10th, 2025
Amplity Rebrand Earns Prestigious Industry Awards

The Titan Awards, an international advertising competition recognizing extraordinary achievements in healthcare advertising and marketing, honored Amplity as a Platinum Winner for Best Rebranding Effort and a Gold Winner for Best Website Design.

PR Newswire
Jun 1st, 2025
The Academy Of Oncology Nurse Patient Navigators And Gilead Sciences Partner To Launch Oncology Navigation Grant Program

GAINESVILLE, Fla., June 1, 2025 /PRNewswire/ -- The Academy of Oncology Nurse & Patient Navigators (AONN+) is proud to announce the launch of a groundbreaking grant program in partnership with Gilead Sciences aimed at advancing the field of oncology navigation and enhancing patient outcomes within the healthcare setting. This initiative is designed to support the creation, enhancement, and expansion of innovative tools that optimize efficiency and elevate the critical role of oncology navigators.Following the AONN+ call for grant submissions in April, healthcare leaders across the country responded with creative applications, software solution ideas and healthcare system improvements. AONN+ looks to announce the recipients of the award, valued up to $500,000, in June with project work to begin in the July time frame. The AONN+ grant application process and implementation support for awardees also included help from Amplity, AONN+'s association management partner and strategic collaborator."Through this funding mechanism, AONN+ and Gilead are committed to addressing persistent challenges in cancer care by empowering navigators to play a pivotal role in improving patient access to navigation services, removing barriers to cancer care, and supporting treatment adherence," says Candice Roth, MSN, RN, CENP, Executive Director, AONN+. "Navigator utilization continues to present significant opportunities for optimizing patient outcomes, and this program seeks to provide impactful solutions that directly tie proposed tools to measurable improvements in patient care.""As part of Gilead's Community Cancer Collective, we are proud to partner with AONN+ on this exciting initiative in support of the oncology community," said Darren Tayama, M.D., Vice President, US Medical Affairs, Oncology. "Together, AONN+ and Gilead are advancing the future of cancer care through innovative solutions in oncology navigation."About the Academy of Oncology Nurse & Patient Navigators , Inc

Amplity
May 28th, 2025
Meet Ava: Amplity's AI Chatbot Enhancing Web UX

Amplity, a full-service partner for outsourcing flexible medical and commercial services, proudly announces the launch of Ava, an AI-powered chatbot designed to deliver faster, more personalized digital experiences on Amplity.com.

Amplity
May 15th, 2025
Amplity Unveils GLP-1 RAs & Biologic Trends At ISPOR 2025

Amplity unveils GLP-1 RAs & biologic trends at ISPOR 2025.

INACTIVE